- Filed
- Mar 24, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Mar 24, 2025 | 2.45M sh |
| Shares Diluted restated | FY 2024 · Dec 31, 2023 | 613K sh |
| Capex | FY 2024 · Dec 31, 2023 | $78.46K |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | −$5.77M |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $4.29M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $624.49K |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $659.94K |
| Current Assets | FY 2024 · Dec 31, 2023 | $5.62M |
| Total Assets | FY 2024 · Dec 31, 2023 | $6.22M |
| Eps Diluted restated | FY 2024 · Dec 31, 2023 | −$10.87 |
| Eps Basic restated | FY 2024 · Dec 31, 2023 | −$10.87 |
| Sga Expense | FY 2024 · Dec 31, 2023 | $3.89M |
| Rd Expense | FY 2024 · Dec 31, 2023 | $662.18K |
| Net Income | FY 2024 · Dec 31, 2023 | −$6.66M |
| Gross Profit | FY 2024 · Dec 31, 2023 | −$119.33K |
| Cost Of Revenue | FY 2024 · Dec 31, 2023 | $1.27M |
| Revenue | FY 2024 · Dec 31, 2023 | $1.15M |
| Stockholders Equity | FY 2024 · Dec 31, 2022 | $4.02M |